
Celerion
Saint-Laurent, QC, Canadacelerion.comFrom their website, Nov 2026
- CLIA
Work here? Claim this listing
About
Celerion is an early-phase clinical research CRO that supports drug development for pharmaceutical and biotech companies. It provides clinical, bioanalytical, regulatory, biometrics, and modeling services from sites in Phoenix, Lincoln, Belfast, and Zurich. The company focuses on helping sponsors make earlier go/no-go decisions in Phase I and clinical pharmacology studies.
Services
Early Phase Clinical Research
Provides comprehensive Phase I and clinical pharmacology services for early drug development programs.
Bioavailability / Bioequivalence Studies
Conducts BA/BE studies for generic drug development and regulatory submissions.
Drug-Drug Interaction (DDI) Studies
Runs interaction studies for complex multi-compound protocols and NDA-enabling programs.
Single Ascending Dose / Multiple Ascending Dose Studies
Performs SAD/MAD and first-in-human dose escalation studies.
Food Effect Studies
Evaluates the effect of food on drug performance in early clinical studies.
Thorough QT (TQT) Studies
Conducts cardiac safety studies to assess QT interval effects.
Radiolabeled (ADME) Studies
Performs radiolabeled absorption, distribution, metabolism, and excretion studies.
Pharmacodynamic (PD) Studies
Carries out pharmacodynamic studies in early-phase development.
12 more services
- Monitoring & Project Management
- Bioanalytical Sciences
- Pharmacokinetics / Pharmacodynamics (PK/PD) Analysis
- Immunogenicity
- Biomarkers
- Biosimilars
- Gene Therapy
- Metabolite Identification and Profiling
- Data Management & Biometric Services
- Modeling and Simulation Services
- Clinical Protocol Development
- Biostatistical Analysis
- Turnaround
- 24 hours
- What to send
- Investigational product
- Interactive medications
Capabilities
- Assays and studies
- PK/PD
- Bioanalysis
- Immunogenicity
- ADME
- Bioavailability
- Bioequivalence
9 more
- Drug-drug interaction
- Single ascending dose
- Multiple ascending dose
- Food effect
- Thorough QT
- Radiolabeled ADME
- Pharmacodynamic
- Biomarker
- Metabolite identification
- Scale and capacity
- More than 650 beds worldwide
- Sites in Phoenix, Arizona
- Sites in Lincoln, Nebraska
- Sites in Belfast, UK
- Sites in Zurich, Switzerland
- 24/7 STAT testing available
- Therapeutic areas
- Respiratory disease
- Metabolic disorder
- Biosimilar clinical research
- Renal impairment
- Hepatic impairment
- Cardiovascular safety
- Cardiovascular efficacy
- Tobacco harm reduction
Instruments and platforms
- ECG Core Lab
- Electronic Data Capture (EDC)
- Electronic Trial Master File (eTMF)
- E-Lab Notebook
- Celexus®
- ClinQuick®
Modalities and species
- Modalities
- Small molecule
- Biosimilar
- Species and models
- CAP/CLIA-accredited clinical laboratory
- USP-compliant compounding suites
Industries served
- Pharmaceutical
- Biotech
- Generic drug development
Details
- Type
- CRO
- Office
- delivering 21 CFR Part 11 validated systems with real-time data visualiza
- Sites
- Phoenix, United States · Lincoln, United States · Belfast, United Kingdom · Zurich, Switzerland
- Serves
- Global